Horizon Therapeutics Newswire (Page 2)

Horizon Therapeutics Newswire (Page 2)

Comprehensive Real-Time News Feed for Horizon Therapeutics. (Page 2)

Results 21 - 40 of 1,958 in Horizon Therapeutics

  1. Schafer: Is Amazon the big game for Twin Cities? Bring it onRead the original story w/Photo

    Tuesday Sep 12 | Star Tribune

    The Twin Cities doesn't have to get Amazon.com's second headquarters and its potential of 50,000 jobs to get a big win out of the new headquarters sweepstakes. Amazon's new headquarters town also has to have a major international airport within 45 minutes of the facility, with nonstop flights daily to places it cares about.

    Comment?

  2. Medtronic Announces Voluntary Recall of Diabetes Infusion SetsRead the original story w/Photo

    Tuesday Sep 12 | US Recall News

    Medtronic plc announced today that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all models of Medtronic insulin pumps. The recall is related to a certain discontinued component in these infusion sets and does not include insulin pumps or glucose sensors.

    Comment?

  3. Medtronic in.Pact Admiral DCB Global Two Year Data and in.Pact Sfa...Read the original story

    Tuesday Sep 12 | GlobeNewswire

    September 12, 2017 - Medtronic plc data announced today reinforce the durability and safety of the IN.PACT Admiral drug-coated balloon in patients with peripheral arterial disease . The two-year, real-world results from the full clinical cohort of the IN.PACT Global Study and four-year results from the pivotal IN.PACT SFA Study were presented in two late-breaking clinical trial presentations at the Vascular Interventional Advances 2017 conference in Las Vegas.

    Comment?

  4. PRI Appoints Kathy Chan and Robert Ryan to Board of Directors to...Read the original story

    Tuesday Sep 12 | PressReleasePoint

    Public Radio International , leader in and producer and distributor of multi-platform storytelling and award-winning journalism that empowers people to benefit their lives and the world, has elected Kathy Chan and Robert Ryan to its Board of Directors. Kathy and Robert add valuable digital expertise and business acumen to PRI's Board ; Kathy is co-founder of growth-stage investment firm, 137 Ventures, whose investments include SpaceX, Spotify, and Eventbrite.

    Comment?

  5. Xact Kapitalforvaltning AB Has $19.71 Million Holdings in Medtronic PLCRead the original story w/Photo

    Tuesday Sep 12 | The Breeze

    Xact Kapitalforvaltning AB lessened its holdings in shares of Medtronic PLC by 0.1% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 222,053 shares of the medical technology company's stock after selling 114 shares during the period.

    Comment?

  6. Medtronic Announces New StealthStation(TM) Technology for Ear, Nose, and Throat ProceduresRead the original story w/Photo

    Tuesday Sep 12 | PR-inside.com

    September 12, 2017 - Medtronic plc today announced the global launch of the StealthStation ENT, a new surgical navigation system designed for surgeons treating conditions within the ear, nose, and throat anatomy. The company has received U.S. Food and Drug Administration 510k clearance and CE Mark for the system.

    Comment?

  7. Medtronic recalls diabetes infusion sets for overdose riskRead the original story w/Photo

    Monday Sep 11 | Boston.com

    Medtronic Plc is recalling a disposable device used with the company's insulin pumps, after discovering that the part can trigger an excessive dose of the drug and put patients at risk of hypoglycemia. About one in every 2 million infusion sets manufactured before April may be associated with the complication, which occurs when a membrane that's used to release pressure from inside the pump gets wet and blocks the vents, said Francine Kaufman, chief medical officer of Medtronic's diabetes group.

    Comment?

  8. Andeavor Honors Top SuppliersRead the original story w/Photo

    Monday Sep 11 | PR-inside.com

    September 10, 2017 - Andeavor is pleased to announce the recipients of its annual Supplier Recognition Awards, selected for outstanding performance in alignment with Andeavor's Guiding Principles. Award recipients were chosen for exceptional performance during the 2016 calendar year, during which they delivered significant results in the award categories.

    Comment?

  9. Medtronic Recalls Diabetes Infusion Sets for Overdose RiskRead the original story

    Monday Sep 11 | The Washington Post

    Medtronic Plc is recalling a disposable device used with the company's insulin pumps, after discovering that the part can trigger an excessive dose of the drug and put patients at risk of hypoglycemia. About one in every two million infusion sets manufactured before April may be associated with the complication, which occurs when a membrane that's used to release pressure from inside the pump gets wet and blocks the vents, said Francine Kaufman, chief medical officer of Medtronic's diabetes group.

    Comment?

  10. Medtronic Announces Voluntary Recall of Diabetes Infusion SetsRead the original story w/Photo

    Monday Sep 11 | PR-inside.com

    September 11, 2017 - Medtronic plc announced today that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all models of Medtronic insulin pumps. The recall is related to a certain discontinued component in these infusion sets and does not include insulin pumps or glucose sensors.

    Comment?

  11. Medtronic PLC (MDT) Upgraded to Hold at Zacks Investment ResearchRead the original story w/Photo

    Sunday Sep 10 | AmericanBankingNews.com

    According to Zacks, "Apart from displaying successful integration and achievement of synergy targets, Medtronic's major business groups continue to contribute to top-line growth which highlighted sustainability across all segments and geographies. Recently, the company announced the receipt of CE Mark for Attain Stability Quad MRI SureScan Active-Fixation heart lead.

    Comment?

  12. Point72 Asset Management L.P. Takes $14.99 Million Position in Medtronic PLCRead the original story w/Photo

    Saturday Sep 9 | Daily Political

    Point72 Asset Management L.P. purchased a new position in shares of Medtronic PLC during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 186,100 shares of the medical technology company's stock, valued at approximately $14,992,000.

    Comment?

  13. Medtronic Announces Japanese Regulatory Approval for the IN.PACT(TM) Admiral(TM) Drug-Coated BalloonRead the original story

    Friday Sep 8 | PressReleasePoint

    September 8, 2017 - Medtronic plc today announced that the IN.PACT Admiral Drug-Coated Balloon received approval from the Japanese Ministry of Health, Labour and Welfare for the treatment of peripheral artery disease in the upper leg - specifically, in the thigh ) and behind the knee . Before Medtronic can begin commercialization, it must partner with Japanese MHLW to gain reimbursement to ensure broader access to this innovative and clinically-proven therapy.

    Comment?

  14. Medtronic Chairman and CEO Omar Ishrak to Speak at Morgan Stanley Global Healthcare ConferenceRead the original story

    Thursday Sep 7 | PressReleasePoint

    September 7, 2017 - Medtronic plc , the global leader in medical technology, today announced that it will participate in the 15th Annual Morgan Stanley Global Healthcare Conference on Monday, September 11, 2017, in New York City. Omar Ishrak, chairman and chief executive officer of Medtronic, will answer questions about the company beginning at 9:20 a.m. EDT .

    Comment?

  15. Songa Offshore SE : Warrants exercised, new shares issuedRead the original story w/Photo

    Thursday Sep 7 | PR-inside.com

    Reference is made to the stock exchange announcement on 7 April 2016 made by Songa Offshore SE regarding the new convertible bond loan issued by the Company on 17 April 2016. The Company has received exercise of 96,998 warrants and have today issued 96,998 ordinary shares in the Company.

    Comment?

  16. APRIL Financial Information // 2017 Half-year resultsRead the original story w/Photo

    Thursday Sep 7 | PR-inside.com

    Please find attached our press release regarding our 2017 Half-year results. You can download our 2017 Half-year results presentation on APRIL's website: www.april.com .

    Comment?

  17. Constellium partners with American Corporate Partners to help...Read the original story w/Photo

    Thursday Sep 7 | PR-inside.com

    Constellium N.V. and and American Corporate Partners today announced a new partnership to help veterans transition to the private sector through one-on-one mentoring relationships with corporate professionals from the company. The program is designed to assist veterans in their long-term career development through mentorship, networking, and career guidance.

    Comment?

  18. 2021 Projections puts Latin America Varicose Vein Treatment Market at 40.17 millionRead the original story

    Thursday Sep 7 | Emailwire.com

    This report provides information about Research Methodology, Drivers, Restraints, Opportunities, Challenges Analysis,market Segmentation, Geographical Analysis, Strategic Analysis & major Leaders of Latin America Varicose Vein Treatment Market. The Latin America Varicose Vein Treatment Market was worth USD 29.05 million in 2016 and estimated to be growing at a CAGR of 6.7%, to reach USD 40.17 million by 2021.

    Comment?

  19. Medtronic Recognized For Its Sustainability LeadershipRead the original story

    Wednesday Sep 6 | BioSpace

    September 7, 2017 - Medtronic plc was recognized today as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability North America Index for the tenth consecutive year. DJSI North America analyzes companies on a variety of sustainability criteria, including economic performance, environmental stewardship, social responsibility, and corporate governance.

    Comment?

  20. Global Spinal Non-Fusion Device Market Research Report 2017Read the original story w/Photo

    Wednesday Sep 6 | PR-inside.com

    Geographically, this report is segmented into several key Regions, with production, consumption, revenue , market share and growth rate of Spinal Non-Fusion Device in these regions, from 2012 to 2022 . The Global Spinal Non-Fusion Device Market Research Report 2017 is a professional and in-depth study on the current state of the Spinal Non-Fusion Device industry.

    Comment?